Physician profile
Mohit Jain
NPI 1659557254
$98,131.07
in general payments reported to CMS, 2019-2025
24 companies · $12K in 2025
The $12K reported for 2025 was more than what 90% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,385 · 2020: $11K · 2021: $11K · 2022: $23K · 2023: $15K · 2024: $24K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $27K · Travel and Lodging: $8,823 · Consulting Fee: $8,250 · Food and Beverage: $7,217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $26,750.00 |
| Travel and Lodging | $8,822.64 |
| Consulting Fee | $8,250.00 |
| Food and Beverage | $7,216.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $64,805.19 | 2020-2025 | Jardiance |
| Abbott Laboratories | $13,944.52 | 2021-2025 | Amplatzer Amulet, Jeti All In One Non-Sterile Kit, Cardiomems |
| Lilly USA, LLC | $12,425.00 | 2020-2024 | Jardiance |
| Boston Scientific Corporation | $4,155.43 | 2019-2025 | Watchman Flx, Avvigo Guidance System, Watchman Access System |
| Medical Device Business Services, INC. | $551.29 | 2024 | Carto 3 |
| Janssen Pharmaceuticals, INC | $397.33 | 2019-2024 | Xarelto |
| Novo Nordisk INC | $264.13 | 2025 | Wegovy, Ozempic |
| Novartis Pharmaceuticals Corporation | $259.98 | 2019-2024 | |
| Pfizer INC. | $257.89 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $156.85 | 2025 | |
| Philips North America LLC | $139.33 | 2019-2024 | (P77) Azurion 7 M20 |
| Edwards Lifesciences Corporation | $133.06 | 2021-2025 | Sapien 3 Ultra Resilia, Inspiris Resilia Aortic Valve |
| Medtronic, INC. | $124.89 | 2024 | Symplicity G3 |
| Amgen INC. | $107.71 | 2023-2025 | Repatha |
| Cardiva Medical, INC. | $105.25 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $100.00 | 2023 | Assure Wcd |
| Merck Sharp & Dohme LLC | $43.40 | 2024-2025 | Winrevair, Verquvo |
| Chiesi USA, INC. | $37.96 | 2020-2024 | Cleviprex, Kengreal |
| Abiomed | $32.69 | 2025 | |
| Penumbra, INC. | $22.31 | 2024 | Penumbra System |
| Alnylam Pharmaceuticals INC. | $19.68 | 2025 | Amvuttra |
| Kiniksa Pharmaceuticals International, Plc | $17.08 | 2024 | Arcalyst |
| Medtronic Vascular, INC. | $15.36 | 2019 | |
| Baylis Medical Company INC | $14.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohit Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.